🔗 Share this article

An underground market for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.

Experimental Treatment Gaining Traction Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing properties. Followers are encouraged to contact these profiles privately for source information, while also obtaining promotional offers.

Active Trade on Social Networks

Additionally, a robust trade exists on messaging services, where groups with numerous of participants share comparison photos, injection guides and claims of next-day British shipping. Vendors market the drug there before redirecting customers to WhatsApp for purchases.

Understanding Retatrutide

This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the successor to Ozempic.

Medical Professionals Voice Concerns

Nevertheless, doctors and pharmacists have cautions that the sale of what remains an unapproved medication in the United Kingdom is a cause for concern and could lead to users injecting substances of unknown origin.

Some experts stated the demand for the experimental drug could be linked to the increasing price of approved weight loss treatments such as Mounjaro.

Legal Position and Enforcement

Marketing retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that cannot be promoted or supplied for personal consumption under the British medical regulations.

Some influencers attempt to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but advertising and distribution can still breach medicines, marketing, and customer laws, potentially leading to penalties, legal action or imprisonment.

Platform Response and Content Removal

Based on the social media company, the service has taken down problematic content and banned related hashtags and search suggestions. The company said it was dedicated to maintaining the platform secure and allocating resources in enhancing compliance measures.

Online Marketplace Activities

Investigations also discovered communities with up to 9,000 members selling retatrutide using the platform's built-in search feature, which functions like a online catalog. Typing “retatrutide” immediately brings up groups with thousands of users, populated with photos of slimming results, positive testimonials and detailed guides for preparing or administering at home.

After moments of joining one community, a vendor posted contact information, where the majority of transactions take place. The vendor provided an instruction manual and guaranteed shipping within two days. When questioned whether the product was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None inquired about body mass, medical conditions or past usage.

Product Information and Costs

Inside these groups, posts display dark colored parcels with postal service stickers, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at residence with sterile water, or pre-filled injectors typically sold at £160 for 20 milligrams. When asked how long a pen should be used, sellers give contradictory answers ranging from a several days to “depends on your body”.

Service Moderation and Safety Measures

A spokesperson for Telegram stated it actively monitored harmful material on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are administering substances they cannot confirm. Although the science behind this drug is sound, these online versions may not include what they claim,” said Jason Murphy, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to recent price rises for approved weight-loss drugs such as Mounjaro. “With prices increasing, individuals are turning to social media. But counterfeit treatments are highly risky. You can’t be certain what’s inside or whether the environment they were made in was sterile,” she explained.

Her team has previously encountered individuals injured by self-injection from unverified sources. “We recognize the frustration, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” said the doctor. “These substances could be impure or improperly measured.”

Producer Statement

A spokesperson from Eli Lilly said the substance was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this time no one can sell [it] for human use,” they explained, adding that any item “falsely representing itself as a company experimental substance not yet approved … may expose users to possibly significant health risks”.